tiprankstipranks
Milestone Pharmaceuticals (MIST)
NASDAQ:MIST
US Market

Milestone Pharmaceuticals (MIST) Financial Statements

421 Followers

Milestone Pharmaceuticals Financial Overview

Milestone Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.337; its P/E ratio is -0.99; Milestone Pharmaceuticals is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is $-0.19. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -6.60M$ -2.76M$ -5.42M$ -8.48M$ -14.95M
EBITDA$ -6.58M$ -2.74M$ -5.34M$ -8.38M$ -14.98M
Net Income Common Stockholders$ -10.35M$ -33.88M$ -6.26M$ -16.04M$ -14.95M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 89.48M$ 65.96M$ 75.75M$ 87.59M$ 100.95M
Total Assets$ 96.00M$ 75.23M$ 87.12M$ 97.02M$ 110.81M
Total Debt$ 52.51M$ 51.77M$ 51.03M$ 50.32M$ 49.69M
Net Debt$ -36.98M$ -14.19M$ -24.72M$ -37.27M$ -51.26M
Total Liabilities$ 56.08M$ 58.45M$ 58.61M$ 56.61M$ 57.15M
Stockholders Equity$ 39.92M$ 16.77M$ 28.50M$ 40.44M$ 53.93M
Cash Flow-
Free Cash Flow$ -8.93M$ -9.83M$ -12.18M$ -10.60M$ -13.94M
Operating Cash Flow$ -8.93M$ -9.80M$ -12.16M$ -10.56M$ -13.90M
Investing Cash Flow$ -27.01M$ 13.68M$ -10.86M$ -28.03M$ 29.97M
Financing Cash Flow$ 32.32M$ 1.00K$ 305.00K$ -2.77M$ 50.25M
Currency in USD

Milestone Pharmaceuticals Earnings and Revenue History

Milestone Pharmaceuticals Debt to Assets

Milestone Pharmaceuticals Cash Flow

Milestone Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis